verified SJR 0,273 · Q3 • database Scopus / SJR & Web of Science & DOAJ indexed

France · Elsevier Masson s.r.l.

workspace_premium Q3 — Pharmacology lock Subscription · DOAJ

Annales Pharmaceutiques Francaises

Annales Pharmaceutiques Francaises is a journal indexed in SJR in Pharmacology and Pharmaceutical Science with an H index of 34. It has an SJR impact factor of 0,273 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,273.

ISSN: 0003-4509

Publisher: Elsevier Masson s.r.l.

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,273 Q3

H-index 34

Acceptance rate pie_chart

37%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,273

H-index

Docs (year)

111

Docs 3y

257

Total refs

4531

Cites 3y

353

Citable 3y

254

Cites/Doc 2y

1.34

Ref/Doc

40.82

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Benzodiazepine dependence: Focus on withdrawal syndrome

Value and payment for oncology in the United States

Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin Bags

Developpement et validation d'une methode de dosage des traces de detergents inactivants totaux du prion

Developpement de nouveaux substituts cutanes a base de polymeres bioresorbables pour la prise en charge des affections cutanees severes

Developpement d'un outil d'aide a la description des interactions et des effets indesirables medicamenteux pour la formation et la routine clinique

Depenses en dispositifs medicaux steriles dans certains actes de chirurgie hepatobiliaire et digestive : que resterait-il du Groupe Homogene de Sejour ?

Conclusion et recommandations

Comportement interfacial de tetraphenylporphyrines glycoconjuguees et leur interaction avec des modeles biomimetiques de la membrane cellulaire

Comparaison entre le co?ªt d'une pose de catheter veineux central d'insertion peripherique et d'une chambre implantable

Centralized intravenous additive services (CIVAS): The state of the art in 2010

Brief historical overview and recent progress on cytochromes P450: Adaptation of aerobic organisms to their chemical environment and new mechanisms of prodrug bioactivation

SHOW MORE ARTICLES

Bioanalyse en chimie medicinale : de la mise au point d'analyses a la conception evolutive de medicaments

<<Effet placebo >>, des convictions personnelles aux representations collectives : relecture psychosociale d'un phenomene pharmacodynamique

Bases de la pharmacologie

Au-dela du diagnostic d'une maladie genetique, la question de l'information de la parentele

Assessment of anti-factor Xa activity of heparin in binary parenteral nutrition admixtures for premature neonates

Aspects specifiques de la production dans le domaine des vaccins

Arrêt de la valorisation humanitaire des medicaments non utilises : enjeux et perspectives

Analyse d'ouvrages

Analyse d'ouvrage

Amine oxidases of the quinoproteins family: Their implication in the metabolic oxidation of xenobiotics

Actualites de la legislation europeenne en matiere d'aliments et d'allegations sante

FAQs

Annales Pharmaceutiques Francaises has an SJR of 0,273 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Annales Pharmaceutiques Francaises is 37%.

Annales Pharmaceutiques Francaises

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Annales Pharmaceutiques Francaises?

What is the APC / publication cost?

What is the acceptance rate?